Dr. Marcus Schabacker became president and chief executive officer of ECRI in January 2018. Dr. Schabacker is a board-certified anesthesiologist and intensive care specialist with more than 35 years of healthcare experience in complex global environments, and more than 20 years of senior leadership responsibilities serving the medical device and pharmaceutical industries across the healthcare value chain.

After his medical and academic training at the Medical University of Lubeck, Germany, Dr. Schabacker served as senior medical officer and head of the intensive care and anesthesia department at the Mafikeng General Hospital, North-West Province, South Africa. His work there was part of a humanitarian aid program to support the African National Congress government under Nelson Mandela in the restructuring and buildup of a rural healthcare system in post-apartheid South Africa.

Upon his return from Africa, Dr. Schabacker joined the medical device industry and held roles of increasing responsibility in medical affairs, preclinical and clinical development, regulatory affairs, quality, research and development, and patient safety. His experience includes designing, transforming, and leading organizations of up to 4,000 employees across five continents to provide safe and effective products to patients and healthcare providers worldwide.

In his last corporate role prior to joining ECRI, Dr. Schabacker served as corporate vice president and chief scientific officer at Baxter. During his clinical years, and his time as an industry thought leader, Dr. Schabacker was focused on patient safety and enhancing patient care.

Dr. Schabacker is a national and international thought leader on patient safety, medical technology, and health equity issues. A sought-after independent expert by health and business reporters, he is often quoted in major news outlets, including USA Today, NY Times, Wall Street Journal, and Modern Healthcare. His broadcast experience includes live and recorded interviews on CNN, CNN International, and CBS-Chicago, plus network-affiliated radio shows. He has presented at national and international conferences.

Dr. Schabacker achieved his board certification in anesthesia and intensive care, as well as a doctorate in medicine from the Medical University, Lubeck, Germany. He also received certifications in emergency medicine and disaster medicine. He is an affiliate assistant professor at The Stritch School of Medicine at Loyola University Chicago. Dr. Schabacker serves as a member of the Life Sciences Advisory Board of Philadelphia. In 2019, Dr. Schabacker was elected into the Fellowship of The College of Physicians of Philadelphia. He has been recognized by the Philadelphia Business Journal as a Healthcare Leader in 2021.

Peter Catalano joined ECRI in 2016 as chief financial officer. He is responsible for financial reporting and controls, development and implementation of sound financial plans and policies, financial analysis, cash management, and the conduct of relationships with lending institutions, creditors, and the financial community.

Catalano began his career at Coopers & Lybrand in Philadelphia. Prior to joining ECRI, Catalano was CFO of asset management within SunGard, and before that he was vice president of global finance position at Ellucian, SunGard's higher education division. Catalano brings extensive experience in service-oriented companies, and he has held high level finance roles in both venture-backed and multi-billion dollar companies. In addition to his finance responsibilities, his achievements include many operational initiatives such as system implementations, customer relationship management (CRM) optimization, and commission streamlining.

Catalano is a graduate of Villanova University and received his MBA from Lehigh University. He is a licensed CPA in the state of Pennsylvania, and is a member of both AICPA and PICPA.

Darryl Goss joined ECRI in February 2024 as Chief Technology Officer. Goss has nearly 30 years of experience in senior leadership positions at public and private equity firms enhancing technological capabilities in the healthcare, pharmaceutical, and chemical industries.

Goss leads the technological transformation and delivery of ECRI’s externally facing products and services. He is driven to provide a high-quality member experience and help healthcare decision-makers leverage data to improve the safety and efficiency of patient care.

For ECRI’s information technology programming, Goss directs internally facing business operations for the organization’s global and mostly remote workforce. Before being named CTO, Goss served as a member of ECRI’s external IT Tech Advisory Council, which was established to offer expert advice on technologies, data strategy and tech roadmaps.

Prior to joining ECRI, Goss served as Chief Executive Officer of Inform Diagnostics, a provider of anatomic pathology laboratory services; President of Sigma-Aldrich Fine Chemicals (SAFC) Hitech, a manufacturing division for pharmaceutical and tech organizations; and Vice President and General Manager of Europe and Asia Pacific for SAFC's life science services. As a healthcare consultant, he was engaged by private equity firms to evaluate and improve company operations, lead strategic planning, and initiate technology investments.

Dheerendra Kommala, MD, is Chief Medical Officer at ECRI, responsible for ECRI’s Medical Office. He joined ECRI in 2019 as Chief Strategy Officer responsible for setting the organization’s strategic direction.

Dr. Kommala brings more than 20 years of experience as an academic clinician, researcher, and chief medical officer. He successfully introduced new products and services to markets throughout the world by working collaboratively with major health systems, industry leaders, clinicians, and patients. Throughout his career, he has been a vocal advocate for patient safety and a visionary leader managing large teams.

Prior to joining ECRI, Dr. Kommala was global vice president of medical affairs for Baxter Healthcare. Previous experience included working as chief medical officer/global vice president of medical affairs for ConvaTec, and as associate medical director of Global Pharmaceutical Research for Renal Care, Abbott Laboratories.

Dr. Kommala received his initial medical training in India, and completed a fellowship in nephrology at the University of Missouri, Columbia School of Medicine.

Stuart Morris-Hipkins joined ECRI in 2021 as Chief Solutions Officer. He serves as a member of ECRI’s Executive Committee and is responsible for sales, marketing, membership services, and the safety and technology business lines.

Morris-Hipkins brings over 20 years of global leadership experience from a variety of different healthcare sectors and industries.

Morris-Hipkins has led multibillion businesses with full leadership responsibility as CEO/President, as well as startups in more than 120 countries. Aside from leadership roles, he has led strategy development, business transformation, mergers and acquisitions (M&A), and revenue growth projects by partnering with healthcare customers globally.

Prior to joining ECRI, Morris-Hipkins founded AFTRR Business Link, Inc., and assisted organizations with strategy, growth, and due diligence projects. Previous experience includes working as president of global solutions at Owens & Minor, chairman at Fusion5 and executive and commercial leadership roles at Smith & Nephew, PLC, and Smiths Group PLC.

Morris-Hipkins holds a Bachelor of Science degree in Mathematics and Chemistry with Honors from Oxford Brookes University, UK, and a Master of Science degree in Atmospheric Sciences from the University of East Anglia, UK. He also holds the professional qualification of Chartered Global Management Accountant (CGMA, ACMA).

Stuart is a citizen of the United Kingdom and the United States.

Bevin O'Neil is the chief strategy officer at ECRI, a nonprofit organization focused on advancing effective, evidenced-based healthcare globally. In her role, O’Neil is responsible for developing and executing its global strategy. O’Neil has over two decades of private equity, fundraising and operating experience, and has sat on several boards.

Prior to ECRI, O’Neil was the founder and managing partner of Incline GEP, which focused on supporting entrepreneurs with emerging consumer brands. From 2011 to 2013, O’Neil served on the drug access team of Clinton Health Access Initiative (CHAI), responsible for improving sustainable access to pediatric HIV drugs and diagnostics for the developing world utilizing a market-based approach.

Earlier in her career, O’Neil was a Principal at Avista Capital Partners, founded by former DLJ Merchant Banking partners. At Avista, O’Neil launched the consumer silo and executed five private equity investments and related tack-on acquisitions in healthcare and consumer, four of which were corporate carve-outs requiring intense operational and infrastructure building. Prior to Avista, O'Neil was a senior manager in business development at Tumi, an Oaktree Capital Management portfolio company. In addition, O'Neil served various roles in the private equity groups of Guggenheim Partners, Oaktree Capital Management, and DLJ Merchant Banking.

O’Neil received a BBA from the University of Michigan.

Lea Rubini joined ECRI in January 2022 as Chief Human Resources Officer. She is a dynamic and trusted leader with over 20 years of global experience across numerous industries. She is known for her inclusive style, business acumen, and ability to quickly move between strategies and tactics.

Throughout her career, Rubini has applied her expertise in driving employee engagement, creating inclusive environments, and affecting change to seamlessly drive business results, transform operating models, and evolve culture. Rubini has proven experience leading global teams in human resources, change management, process improvement, and talent management.

Prior to joining ECRI, Rubini held leadership positions of increasing responsibility in the healthcare, pharmaceutical and consumer goods industries, including at Penn Medicine, Johnson & Johnson, Bristol Myers Squibb, and Campbell Soup Company, to list a few.

Rubini holds a Master’s degree in organizational dynamics from the University of Pennsylvania and a Bachelor's degree in labor and industrial relations from Penn State University. She is certified to facilitate the Hogan Leadership Assessment, Talent X7 Leadership Assessment, and LIFO Behavioral Styles Assessment. She holds coaching and organizational change certificates from the University of Pennsylvania and is a SHRM Senior Certified Professional (SHRM-SCP).

Randy White joined ECRI in 2019 as chief legal officer. He serves as a member of ECRI’s Executive Committee and is also ECRI’s chief privacy officer. Overseeing ECRI’s legal department and outside counsel, Randy is responsible for all of ECRI’s legal affairs in the United States, Europe, and Asia Pacific.

Prior to his current role, Randy spent twenty years as a partner at Fox Rothschild LLP, a nationwide Am Law 100 firm. A partner in Fox’s litigation and labor and employment departments, Randy advised and litigated on behalf of executives, directors, and publicly and privately held companies across the country. At Fox, Randy also served as outside general counsel for nonprofits, start-ups, and middle market companies, overseeing transaction and litigation teams.

Randy holds a juris doctor with honors from the Dickinson School of Law and a bachelor’s degree in government from St. Lawrence University. He is a member of the bars of the Commonwealths of Massachusetts and Pennsylvania, and has been admitted to practice before numerous federal courts.